" class="no-js "lang="en-US"> Palamedrix - Medtech Alert
Tuesday, August 19, 2025
Palamedrix | Pharmtech Focus

Palamedrix

About Palamedrix

Palamedrix


Palamedrix is a DNA nanotechnology based company building a disruptive tool for life sciences and medicine. By utilizing biosensors engineered to capture small molecules present in biological samples, we can pinpoint the presence of any analyte with single-molecule accuracy. Further, organizing the molecular sensors using proprietary CMOS technologies, the Palamedrix platform is capable of delivering comprehensive data for doctors and patients to get a highly-accurate, complete view of an individual’s biochemistry with a single test. This comprehensive dataset enables biochemical insights for informed diagnoses and therapeutic interventions, forging a new era of data-driven healthcare.

Related Story

Somalogic Acquires DNA Nanotechnology Leader Palamedrix to Develop the Next-generation SomaScan® Assay

July 27 2022

SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into […]